We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$541B
AUM Growth
+$82.1B
Cap. Flow
+$80.6B
Cap. Flow %
14.9%
Top 10 Hldgs %
15.6%
Holding
10,816
New
1,380
Increased
6,046
Reduced
2,042
Closed
943

Sector Composition

Rank Sector Weight
1 Technology 18.49%
2 Financials 9.06%
3 Consumer Discretionary 7.01%
4 Healthcare 6.25%
5 Industrials 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVA
10701
DELISTED
Enviva Inc.
EVA
-9,606
Closed -$3.89K
HHGC
10702
DELISTED
HHG Capital Corporation Ordinary Shares
HHGC
-1,852
Closed -$20.6K
HHGCW
10703
DELISTED
HHG Capital Corporation Warrant
HHGCW
-87
Closed
AAN
10704
DELISTED
The Aaron's Company Inc
AAN
-162,905
Closed -$1.62M
AUGX
10705
DELISTED
Augmedix, Inc. Common Stock
AUGX
-17,547
Closed -$41.2K
EGRX
10706
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
-480
Closed -$1.79K
DXYN
10707
DELISTED
Dixie Group Inc
DXYN
-546
Closed -$382
PRFT
10708
CALL
DELISTED
Perficient Inc
PRFT
-90,200
Closed -$6.81M
PRFT
10709
DELISTED
Perficient Inc
PRFT
-885,295
Closed -$66.8M
XFINW
10710
DELISTED
ExcelFin Acquisition Corp Warrant
XFINW
-48,196
Closed -$7.18K
PWSC
10711
DELISTED
PowerSchool Holdings, Inc.
PWSC
-9,547
Closed -$218K
TSLH
10712
DELISTED
Innovator Hedged TSLA Strategy ETF
TSLH
-77
Closed -$2.23K
SWN
10713
DELISTED
Southwestern Energy Company
SWN
-3,383,144
Closed -$24.1M
AFTY
10714
DELISTED
Pacer CSOP FTSE China A50 ETF
AFTY
-410
Closed -$6.77K
ENG
10715
DELISTED
ENGlobal Corp
ENG
-3,979
Closed -$5.05K
KSM
10716
DELISTED
DWS Strategic Municipal Income Trust
KSM
-1,263
Closed -$12.9K
NTG
10717
DELISTED
Tortoise Midstream Energy Fund, Inc. Common Stock
NTG
-19,370
Closed -$921K
GENE
10718
DELISTED
Genetic Technologies Ltd.
GENE
-8,866
Closed -$6.87K
TRVN
10719
DELISTED
Trevena, Inc.
TRVN
-13,346
Closed -$49.9K
VINO
10720
DELISTED
Gaucho Group Holdings, Inc. Common Stock
VINO
-2,688
Closed -$13.8K
LYT
10721
DELISTED
Lytus Technologies Holdings PTV. Ltd. Common Shares
LYT
-11,813
Closed -$21.6K
ONCT
10722
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
-1,221
Closed -$1.61K
NSTB.WS
10723
DELISTED
Northern Star Investment Corp. II Redeemable warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTB.WS
-133
Closed -$1
NVOS
10724
DELISTED
Novo Integrated Sciences, Inc. Common Stock
NVOS
-48,752
Closed -$13.7K
EFSH
10725
DELISTED
1847 Holdings LLC
EFSH
-499
Closed -$13.6K

Similar funds

UBS Group's Q4 2024 Portfolio in Review

As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,380 new positions and adding to 6,046 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.

  • UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
  • UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
  • UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
  • UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
  • UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
  • UBS Group opened 1,380 new positions and closed 943 in Q4 2024.
  • UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.